PATENT CLAIM ANALYSIS

Application Number: 16124583
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "04400A"]

Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting SMAD7 expression, which may be useful for treating, preventing, or ameliorating a disease associated with SMAD7.

Claim (Index 52):
A method of reducing or inhibiting inflammation in the gastrointestinal tissues of an individual having, or at risk of having, a disease associated with SMAD7 comprising administering the compound of  claim 6  to the individual, thereby reducing or inhibiting inflammation in the gastrointestinal tissues of the individual, wherein the individual has, or is at risk of having, ulcerative colitis, Crohn's disease, inflammatory bowel disease, indeterminate colitis, familial adenomatous polyposis, intestinal GvHD, or cancer therapy-induced colitis.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 97.0
- Lexical Diversity: 1.26923
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15484858', '15562843', '14137111', '13452703', '15849017']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7624331981007896
- 35 USC 102 Novelty (BERT): 0.5630084592477436
- Combined Prediction Score: 0.742490724215485
- Mean Citation Score: 334.025172
- Max Citation Score: 341.91788
- Similarity Product: 199.5970520578242

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test